BioSpace News Archive

Covalon Technologies Ltd. today announced that it has appointed Jason F. Gorel as its interim Chief Financial Officer.

Numinus Wellness Inc. is pleased to announce that it has formally submitted the clinical trial application to Health Canada for its Phase 1 study, HOPE, on a naturally derived Psilocybe extract formulation, NBIO-01.

A couple of essential biomolecules play a key role in the process of blood clotting. One of these is a protein called fibrinogen.

Medlab Clinical Ltd (ASX:MDC) is pleased to announce in collaboration with Prof Pall Thordarson (Director of the UNSW RNA Institute, UNSW) and Prof Daniela Traini (NHMRC Investigator, Biomedical Sciences, Macquarie University and The Woolcock Institute of Medical Research) received a NSW Government grant to develop a Proof-of-Concept NanoCelle® Nasal RNA vaccine.

As of December 2021, Dr. Luciano Martelotto has joined the ambitious and AI-driven deep biotech start-up Omniscope as Chief Technology Officer, to support the company’s vision of bringing healthcare for everyone, everywhere.

According to Emergen Research, the global asthma spacers market size was USD 1.91 billion in 2020 and is expected to reach USD 2.46 billion in 2028 and register a revenue CAGR of 3.4% during the forecast period, 2021-2028.